Cofrogliptin
Cofrogliptin (HSK7653) is an oral DPP-4 inhibitor developed for type 2 diabetes research. It exhibits hypoglycemic activity by inhibiting the degradation of incretin hormones, making it suitable for in vitro enzymatic assays and in vivo metabolic studies in diabetic animal models.
Product Specifications
CAS Number
1844874-26-5
Field of Research
Protein Biochemistry
Purity
99.25% (May vary between batches)
Smiles
C (F) (F) (F) [C@@H]1[C@@H] (C[C@H] (N) [C@H] (O1) C2=C (F) C=CC (F) =C2) N3CC=4C (C3) =NN (S (C) (=O) =O) C4
Molecular Formula
C18H19F5N4O3S
Molecular Weight
466.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
JH915006 1 Each
Benzenamine, N-[4- (4-dibenzofuranyl) phenyl]-N-phenyl-4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -
Sign In for Pricing
View Details 